Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Rabbit Polyclonal (IgG) to Human OPRD1 / Delta Opioid Receptor
ICC, Western blot, ELISA
Human OPRD1 / Delta Opioid Receptor
Human (tested or 100% immunogen sequence identity)
Specificity and Use
OPRD1 / Delta Opioid Receptor antibody was raised against peptide analog of the carboxyl terminal of the delta opioid receptor covalently attached onto a carrier protein.
Recognizes delta Opioid Receptor (360-372) and the reactivity of Delta Opioid Receptor is 60%. Does not react to Mu Opioid Receptor (391-398), Mu Opioid Receptor, Kappa Opioid Receptor (346-380) and Kappa Opioid Receptor. Specific for the COOH terminal of the delta opioid receptor.
Suitable for use in ELISA, Western Blot and Immunocytochemistry.
G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance.